Fritextsökning
Innehållstyper
-
New treatment recommended for children with brain tumours
The European Medicines Agency has recommended conditional approval of a new targeted treatment for children with the brain tumour pediatric low-grade glioma.
-
New ZEISS Crossbeam 750 FIB-SEM for high-accuracy sample preparation workflows
Advances in simultaneous SEM imaging while FIB milling provide unmatched feedback for precision endpointing.
-
Cinclus welcomes FDA announcement on single‑study requirement
Swedish Cinclus Pharma welcomes the signals from the United States that a single pivotal study, rather than two, may be sufficient when applying for market approval.
-
Multicancer test failed to meet its goal – shares plunged
A blood test designed to detect multiple types of cancer failed to meet its primary endpoint in a large UK study. The company behind the test saw its market value cut in half.
-
Meet ZEISS at ELRIG Advances in Cell-based Screening 2026
Reserve your spot now.
-
ISO 13485 Standard Internal Auditing Course
Do you work with medical devices and quality management? Strengthen your expertise with our ISO 13485 Standard Internal Auditing Training — designed to give you...
-
Painkiller cuts recurrence risk by more than 50% – national guidelines updated
Sweden’s national guidelines for colon and rectal cancer have been updated — just nine months after the previous revision. The move follows new Swedish research...
-
Quretech granted a European patent for a new type of antibiotic
The European patent provides protection until 2041. Previously, the patent was granted in China, and the application is currently under review in the USA, India, and Japan.
-
Clinical evaluation of class I medical devices
The Swedish Medtech Regulatory Summit is just around the corner — taking place on March 12th at Hilton Slussen in Stockholm. We’re proud to share that our Senio...
-
Genovis ramps up in ADC technology: “An area where we’re seeing very strong interest”
With new products and an expanded licensing agreement in hand Genovis now has a partly new focus for its operations: ADCs – or antibody‑drug conjugates.
-
Asgard teaches tumours to self‑destruct – moving closer to clinical trials
Swedish biotech Asgard Therapeutics not only has an evocative name, but also a remarkably exciting approach to cancer treatment: getting tumour cells to reprogr...
-
“BioArctic is Leqembi, but also much more”
What once began as a small Swedish biotech company has grown into a fully fledged pharmaceutical company with global reach. At the helm is Gunilla Osswald, who ...
-
National cord blood bank resumes collection
The collection of umbilical cord blood is now resuming during planned caesarean sections at Östra Hospital in Gothenburg. The blood remaining in the placenta an...
-
Are you prepared for the updated ISO 10993 1:2025?
The latest edition of ISO 10993-1 reinforces the integration of biological evaluation with risk management, introduces updated approaches to exposure assessment...
-
The Versatile Solution for Quality Management and Data Analysis
Join our ZEISS PiWeb webinar on March 26.
-
Cell-free cartilage from Lund could pave the way for new bone transplants
Researchers at Lund University have developed a new method for repairing large bone defects, based on laboratory-engineered, cell-free cartilage grafts. The tec...
-
Samuel Lagercrantz: ”Obesity, blockbusters and Swedish biotech”
The development of technologies to bypass the blood-brain barrier is particularly exciting right now, as it holds the potential to unlock new treatments for a r...
-
Swedish drug development projects in Phase III – studies to keep an eye on
Developing new medicines is, as we know, a lengthy and uncertain process, and only a fraction of all projects ever reach late clinical phase. But it does happen...
-
Dying man saved by artificial lung system
An external artificial lung system kept a critically ill man alive for two days until he could undergo a lung transplant. In the longer term, researchers hope t...
-
International medical graduates leave Sweden in high numbers
Three years after completing their studies, 46 percent of international doctoral students who graduated in the medical field had left the country. This is shown...
-
Internal audits based on ISO 13485 for medtech organizations
Are you ready to turn your internal audits into real improvements? Internal auditing isn’t just about compliance—it’s a strategic tool for driving development a...
-
Finland leads the way in the hunt for international top researchers
Several Nordic initiatives are currently under way to recruit international top researchers. Finland is making its largest national investment ever in attractin...
-
Lundbeck appoints Chief AI Officer
Danish pharmaceutical company Lundbeck has appointed Markus Kede as Chief AI Officer. He will join the Executive Leadership Team and report to President and CEO Charl van Zyl.
-
Study: Autism as common in girls as in boys
Autism may be just as common in girls as in boys, but girls are diagnosed significantly later and less often during childhood, according to a large Swedish registry study.
BREAKING